BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16337049)

  • 1. Food-drug interactions.
    Cheng TO
    Int J Cardiol; 2006 Jan; 106(3):392-3. PubMed ID: 16337049
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel oral anticoagulants and diet: the potential for interaction.
    Kamali F
    Am J Hematol; 2009 Apr; 84(4):260-1. PubMed ID: 19253346
    [No Abstract]   [Full Text] [Related]  

  • 3. [Atrioventricular complete heart block developed due to verapamil use together with honey consumption].
    Onrat E; Kaya D; Barutçu I
    Anadolu Kardiyol Derg; 2003 Dec; 3(4):353-4. PubMed ID: 14675888
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinically significant drug-drug and drug-food interactions associated with calcium channel blockers].
    Imaura M; Ohno Y; Nakajima K; Suzuki H
    Clin Calcium; 2005 Oct; 15(10):1709-16. PubMed ID: 16199918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aging and coagulation.
    Sane DC
    Clin Adv Hematol Oncol; 2003 Oct; 1(10):583-4. PubMed ID: 16258454
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecule of the month. Ximelagatran.
    Drug News Perspect; 2004; 17(1):66. PubMed ID: 14993935
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical trials of new anticoagulants.
    Anderson J; O'Donnell M
    Vnitr Lek; 2006 Mar; 52 Suppl 1():123-6. PubMed ID: 16637460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A better way to prevent blood clots? A drug derived from cobra venom offers an alternative to warfarin, although liver problems temper its benefits.
    Harv Heart Lett; 2005 May; 15(9):3. PubMed ID: 15898148
    [No Abstract]   [Full Text] [Related]  

  • 9. Current challenges of anticoagulant treatment.
    Ginghină C; Giuşcă S; Serban M; Popescu BA; Jurcuţ R; Uscăţescu V
    Rom J Intern Med; 2007; 45(3):221-7. PubMed ID: 18333353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The respective and combined anticoagulant effects of recombinant human activated protein C, melagatran and heparins using CAT.
    Cimenti C; Koestenberger M; Leschnik B; Haidl H; Muntean W
    Thromb Res; 2007; 119(3):361-7. PubMed ID: 16712904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of grapefruit juice and calcium channel blockers.
    Sica DA
    Am J Hypertens; 2006 Jul; 19(7):768-73. PubMed ID: 16814135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melagatran prevents tissue factor expression in human platelet-monocyte heterotypic complexes.
    Belliard A; Mauco G; Bonnet ML; Hauet T; Macchi L
    Cell Mol Biol (Noisy-le-grand); 2008 Dec; 54 Suppl():OL1077-82. PubMed ID: 19149969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonbleeding complications of unfractionated and low-molecular weight heparins.
    Eikelboom J
    Clin Adv Hematol Oncol; 2007 Nov; 5(11):871-3. PubMed ID: 18185483
    [No Abstract]   [Full Text] [Related]  

  • 14. Ximelagatran increases membrane fluidity and changes membrane lipid composition in primary human hepatocytes.
    Sergent O; Ekroos K; Lefeuvre-Orfila L; Rissel M; Forsberg GB; Oscarsson J; Andersson TB; Lagadic-Gossmann D
    Toxicol In Vitro; 2009 Oct; 23(7):1305-10. PubMed ID: 19616086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melagatran reduces advanced atherosclerotic lesion size and may promote plaque stability in apolipoprotein E-deficient mice.
    Bea F; Kreuzer J; Preusch M; Schaab S; Isermann B; Rosenfeld ME; Katus H; Blessing E
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2787-92. PubMed ID: 16990551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soy and corn allergies--rising in incidence and linked with other allergies.
    AllergyKids
    School Nurse News; 2007 Sep; 24(4):9. PubMed ID: 17913098
    [No Abstract]   [Full Text] [Related]  

  • 17. [Food additives. A possible reason for drug complications-adverse effects?].
    Lokken P; Lunde PK
    Tidsskr Nor Laegeforen; 1972 Aug; 92(24):1541-3. PubMed ID: 5076544
    [No Abstract]   [Full Text] [Related]  

  • 18. [Safety of food supplements containing plant components].
    Kukes VG; Bulaev VM; Sychev DA; Shikh EV
    Vopr Pitan; 2005; 74(4):22-6. PubMed ID: 16265911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemostatic effect of activated factor VII without promotion of thrombus growth in melagatran-anticoagulated primates.
    Gruber A; Carlsson S; Kotzé HF; Marzec U; Sarich TC; Hanson SR
    Thromb Res; 2007; 119(1):121-7. PubMed ID: 16448687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Foods as interfering factors in pharmacotherapy--shown by various examples].
    Becker G
    Med Welt; 1978 Jul; 29(29-30):1163-6. PubMed ID: 353441
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.